Sesquiterpene lactones containing a-methylene-g-lactones, zaluzanin D 1 and zaluzanin C 2 were isolated from the leaves of Vernonia arborea. Several diverse Michael adducts (3-22) and Heck arylation analogs (23-34) of 1 have been synthesized by reacting with various amines and aryl iodides, respectively and were assayed for their in vitro anticancer activities against human breast cancer cell lines MCF7 and MDA-MB-231. Among all the synthesized analogs, Michael adducts 9 and 10 showed better anticancer activities as compared to 1. However, among these compounds, only 10 has minimal cytotoxic effect on normal breast epithelial MCF10A cells. Our detailed mechanistic studies reveal that compounds 9 and 10 execute their antiproliferative activity through induction of apoptosis and thereby inhibit the cancer cells proliferation and compound 10 could be a lead compound for designing potential anti-cancer compound.
Introduction
The generation of diverse chemical libraries using natural products as scaffolds is considered as one of the effective methods for drug discovery.
1 Sesquiterpenes bearing a,bunsaturated g-lactones are ubiquitous in nature and have been reported to be isolated from various genera of the family Asteraceae but also occur sporadically in other angiosperm families, Apiaceae, Magnoliaceae and even in some liverworts. They exhibit diverse biological activities such as anti-microbial, anti-inammatory, antiulcer, antiviral, anticancer and antimalarial activities.
2 The genus Vernonia (family Asteraceae) consists of approximately 1000 species of herbs and shrubs.
3 Several research groups have isolated structurally diverse sesquiterpene lactones from various species of genus Vernonia possessing various biological properties (Fig. 1) .
4,5 Sesquiterpene lactones react with nucleophilic sulydryl groups present in enzymes, proteins, and glutathione. 6 The use of sesquiterpene lactones as therapeutic agents is limited due to their poor water solubility.
To overcome this, amino-adducts of sesquiterpene lactones have been prepared by adding different amines to the a-methylene-g-lactone substructure to enhance the water solubility of the parent molecules and to retain their biological activity.
7,8
Regeneration of parent a,b-unsaturated g-lactone occurs by the retro-Michael reaction, potentially through bioactivation at the site of action. This prodrug approach has transformed several sesquiterpene lactones such as alantolactone, ambrosin, arglabin, costunolide, helenalin, parthenolide and ivangustin, into successful clinical candidates (Fig. 1) . 8 Continuing our interest in naturally occurring sesquiterpene lactones 9 and other bioactive secondary metabolites, we wished to take up the chemical examination of V. arborea leaves for the isolation of bioactive secondary metabolites, zaluzanin C and zaluzanin D. In the present study, several structurally diverse Michael adducts of zaluzanin D have been synthesized with the formation of one or two new C-N bonds. Analogs of zaluzanin D with a new C-C bond formation have also been synthesized by using Pd catalyzed Heck coupling reaction. The in vitro anticancer activities of all the analogs were tested against human breast cancer cell lines MCF7 and MDA-MB-231.
Results and discussion
A portion of the petroleum ether extract (5.3 g) was ash chromatographed on CombiFlash Companion, Isco Teledyne Inc., USA using RediSep® column (SiO 2 , 2 Â 12 g) and elution was carried out isocratically with ethyl acetate-petroleum ether (4 : 96) to furnish a colorless solid. It was identied as zaluzanin D 1, a sesquiterpene lactone having guaianolide skeleton (amethylene-g-lactone) based on its NMR and HRMS spectra and comparison with an authentic sample 10 ( Fig. 2) . Further ash chromatography with ethyl acetate-petroleum ether (6 : 94) furnished zaluzanin C 2. Finally, we proved the structure of zaluzanin D 1 by its single crystal X-ray analysis (Fig. 3) .
11
Both these compounds were assayed against human breast cancer cell line, MCF7 and zaluzanin D 1 exhibited an IC 50 value of 53.7 mM whereas zaluzanin C 2 was found to be inactive ( Table 2) .
Synthesis of Michael adducts of zaluzanin D using different chiral/achiral amines
Since Michael addition of primary or secondary amines to a,bunsaturated lactones resulted in the compounds possessing higher anticancer activities compared to the original compound, 7, 8 we wished to synthesize a library of amino adducts of zaluzanin D with one or more new C-N bonds. The amino derivatives of zaluzanin D 1 were synthesized via Michael addition of different amines to the a,b-unsaturated g-lactone functionality present in zaluzanin D. As shown in Scheme 1, a methanolic solution of chiral/achiral amine and zaluzanin D underwent Michael addition at room temperature to furnish various Michael adducts of zaluzanin D, 3-22 (Table 1 ). Michael addition of chiral amine (S)-(À)-a-methylbenzylamine to zaluzanin D furnished a mixture of two products, compound 3 and its corresponding deacetylated product 4 (entry 1, Table 1 ) which were isolated by ash chromatography. The formation of deacetylated product 4 may be due to the in situ formation of zaluzanin C, which in turn formed due to the basicity of amine, used in the Michael addition.
Addition of the amine to zaluzanin D was found to be diastereoselective, and the stereochemistry of C-11 in compound 3 was assigned 12 as a by its NOESY experiment. In the NOESY spectra of compound 3, correlations were observed between 6b-H and 11b-H. Also, 5a-H showed a correlation with 7a-H (Fig. 4) . 
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Similarly, the reaction of zaluzanin D 1 with (R)-(+)-a-methylbenzylamine resulted in the formation of compounds 5 and 6. The reaction of zaluzanin D 1 with (S)-and (R)-1-(1-naphthyl) ethylamine also furnished the compounds 7, 8 and 9, 10 respectively (entries 3 and 4, Table 1 ). However, reaction with (R)-and (S)-1-cyclohexylethylamine furnished the deacetylated product only (compounds 11 and 12, entries 5 and 6, Table 1 ). Next, we carried out the reaction of zaluzanin D 1 with various six and ve-membered cyclic amines, which furnished corresponding C-N derivatives of zaluzanin D 1 (entries 7-11, Table  1 ). 4-Hydroxypiperidine and morpholine on reaction with zaluzanin D 1 yielded acetylated products (13 and 17) and deacetylated products (14 and 18) , respectively (entries 7 and 9, respectively, Table 1 ). An interesting result was obtained in case of piperazine (entry 9, Table 1), which furnished acetylated dimer 15 and mono deacetylated dimer 16 with two new C-N bonds on both sides of piperazine. However, pyrrolidine and piperidine resulted in the formation of deacetylated products only (19 and 20, respectively) (entries 10 and 11, Table 1 ). Further, we tried to form a C-N bond of zaluzanin D 1 with amino acid methyl ester hydrochlorides (entries 12 and 13, Table 1 ). In this case, K 2 CO 3 was used as a base for in situ generation of the free amine, which on reaction with zaluzanin D 1 furnished the deacetylated product 21. However, in case of valine methyl ester hydrochloride, excess use of K 2 CO 3 resulted in the C-O bond formed product 22.
Synthesis of Heck arylated analogs of zaluzanin D using different aryl iodides (23-34)
Although several structural modications such as Michael addition, reduction, cyclopropanation of the double bond, oxidation of hydroxyl group of sesquiterpene lactones have been reported in literature, transition metal catalyzed cross coupling reactions of sesquiterpene lactones were less explored. 13 We presumed that Heck arylation of a,b-unsaturated g-lactone core of zaluzanin D would provide additional information on structure-activity data of zaluzanin D. As shown in Scheme 2, Heck arylation analogs of zaluzanin D were synthesized using the standard Heck coupling conditions (5 mol% Pd(OAc) 2 , Et 3 N in DMF at 80 C) and readily available aryl iodides.
It is pertinent to mention here that arylation preferred to take place at the exo-methylene of a,b-unsaturated g-lactone substructure over the other two isolated exo-methylene groups present in zaluzanin D 1 which resulted in the exclusive formation of E-olen 14 containing products only (Table 2) .
In vitro anticancer activities of Michael adducts of zaluzanin D (3-22)
Since zaluzanin D 1 had exhibited anticancer activity against human breast cancer cell line (Table 3) , we screened all the synthesized compounds for their antiproliferative activity against breast cancer cell line MCF7 and selected compound in MDA-MB-231. Cells were grown in the presence of different concentrations (0-100 mM) of the synthesized compounds for 48 h and then MTT assay was performed as described in the experimental section. Among these compounds 1, 9, 10 and 14 showed activity (IC 50 < 50 mM) against MCF7 and MDA-MB-231 (Table 3 and Fig. 5 ). Among these four compounds, (R)-1-(1-naphthyl)ethylamine adducts of zaluzanin D and C (i.e. 9 and 10) were found to possess most potent antiproliferative effect (IC 50 30 mM and 18.8 mM, respectively) against MCF7 cells as compared to other synthesized compounds. Interestingly, compound 9 was found to possess more potent antiproliferative activity in highly metastatic MDA-MB-231 cell line (IC 50 13.33 mM) as compared to MCF7 (IC 50 30 mM) suggesting that 9 could be more effective in inducing cell death in higher grades of breast cancer. However, it also has potent cytotoxic effect on the normal breast epithelial MCF10A cells suggesting that compound 9 could not be useful for therapeutic purpose ( Fig. 5c and Table 3 ). Interestingly, compound 10 has the minimal cytotoxic effect against the MCF10A suggesting that it could be a better candidate compound for further designing the small molecule to chemotherapy ( Fig. 5c and Table 3 ). The in vitro anticancer activities of all the synthesized Michael adducts are depicted in Table 3 .
To understand the inhibition of proliferation of cancer cells by these compounds, we have performed the FACS as described in the experimental section. Results showed that treatment of MCF7 cells with 9 and 10 signicantly increased the apoptotic populations while compound 1 and 14 induced apoptosis to a lesser extent indicating that compounds 9 and 10 execute their antiproliferative activity through induction of apoptosis (Fig. 6a) . To validate the apoptotic induction by these two compounds (9 and 10), we then checked fragmentation prole of genomic DNA following their treatment.
15 Results demonstrated that the presence of substantial fragmented DNA ladder following treatment of MCF7 cells with these compounds (Fig. 6b) . Similar results were also observed in vivo upon staining the DNA with Hoechst (Fig. 6c) . Results taken together revealed that compound 9 and 10 are the potent inducer of apoptosis and thereby inhibits the cancer cells proliferation. We then checked the apoptotic pathway and found that 9 and 10 induced apoptosis through the intrinsic pathway of apoptosis through cleavage of caspase 9 (Fig. 6d) . 16, 17 Collectively these results suggest that 9 and 10 may function as anticancer agents through induction of intrinsic apoptosis.
In vitro anticancer activities of Heck analogs of zaluzanin D (23-34)
All the synthesized Heck analogs 23-34 were assayed for their antiproliferative activity against breast cancer cell line MCF7 as described in experimental section. Among all the synthesized Heck analogs, two analogs, 31 and 32 exhibited good antiproliferative activity with IC 50 values of 37 and 36.5 mM, respectively. Compound 29 showed moderate activity with IC 50 and TOF mass analyzer. FT-IR spectra were recorded on an FT-IR-8300 Shimadzu spectrometer. Optical rotations were recorded on a JASCO P-1020 polarimeter.
Plant material
The aerial parts of V. arborea were collected from the Kolli Hills (Perumakkai Shola), Tamilnadu, India during March 2013. The plant was identied by Prof. Dr N. Parthasarathy, Department of Ecology and Environmental Sciences, Pondicherry University, India where a voucher specimen (no. 5318) is being maintained.
Extraction and isolation
Air-dried and grounded leaves (2.8 kg) of V. arborea were extracted with petroleum ether (5 Â 5.0 L) at room temperature for ve days. Aer completion of the extraction, the solvent was evaporated under reduced pressure to afford the petroleum ether extract (105 g). The remaining plant material was further extracted with MeOH (5 Â 5.0 L) at room temperature for ve days. Aer completion of the extraction, the solvent was evaporated under reduced pressure to afford the MeOH extract (224.15 g). A portion of the petroleum ether extract (5.3 g) was ash chromatographed on CombiFlash Companion, Isco Teledyne Inc., USA using RediSep® column (SiO 2 , 2 Â 12 g, stacked together) and isocratic elution was done with ethyl acetatepetroleum ether (4 : 96) to furnish the pure compound (66.3 mg, 0.04%) which was identied as zaluzanin D 1 on the basis of its spectral data, comparison of spectral data with reported data 10 and co-TLC with an authentic sample. Further ash chromatography with ethyl acetate-petroleum ether (6 : 94) furnished a pure compound, which was identied as zaluzanin C 2 (16.3 mg, 0.0098%) on the basis of its spectral data and comparison of spectral data with reported data. (m, 2H), 2.11 (s, 3H), 1.90-1.72 (m, 1H), 1.58-1.45 (m, 1H); 13 C NMR (50 MHz, CDCl 3 ) d C 170. 8, 170.0, 148.1, 147.8, 139.6, 120.4, 114.4, 113.6, 83.8, 74.7, 50.3, 45.3, 44.6, 36.5, 34.6, 30.6, 21. General procedure for the synthesis of amino derivatives of zaluzanin D 1 (3-22)
Zaluzanin D 1 (1 equiv.) was dissolved in dry MeOH (5 mL) and then amine (1.5 equiv.) was added to it and stirred at rt for overnight under argon. Aer completion of the reaction (TLC), the reaction mixture was evaporated to dryness and the residue was puried using CombiFlash R f 200i with UV/VIS and ELSD, Isco Teledyne Inc. using RediSep® column (12 g, SiO 2 ) and eluted with EtOAc-petroleum ether (0 / 70%, gradient) to furnish the pure amino derivatives 3-22.
General procedure for the synthesis of Heck arylated analogs of zaluzanin D 1 (23-34)
To a mixture of aryl halide (3 equiv.) and palladium(II) acetate (5 mol%) in DMF was added zaluzanin D (1 equiv.) and stirred at room temperature for 10 min and then triethylamine (7 equiv.) was added to the reaction mixture and heated at 80 C under air for 24 h. Aer completion of the reaction (TLC), the reaction mixture was allowed to cool to room temperature, water (2 mL) was added, and the resultant mixture was extracted with EtOAc (5 mL Â3). The organic layers were dried over Na 2 SO 4 and concentrated under reduced pressure and then puried using CombiFlash R f 200i with UV/VIS and ELSD, Isco Teledyne Inc. using RediSep® column (12 g, SiO 2 ) and eluted with EtOAc-petroleum ether (0 / 70%, gradient) which furnished the pure aryl derivatives of zaluzanin D.
(3R,3aS,6aR,8S,9aR,9bS)-6,9-Dimethylene-2-oxo-3-((((S)-1-phenyl ethyl)amino)methyl)dodecahydroazuleno [4,5-b] 8, 170.8, 148.6, 148.5, 144.9, 128.6, 127.2, 126.8, 113.6, 113.2, 84.3, 74.8, 58.4, 50.0, 47.3, 45.0, 44.5, 44.1, 36.4, 36.1, 32.1, 29.8, 24.5, 21.3 9, 153.4, 148.8, 144.9, 128.8, 128.6, 127.8, 126.8, 126.2, 113.6, 110.9, 84.4, 73.5, 58.4, 51.1, 47.2, 45.4, 44.5, 43.7, 38.9, 35.9, 29.8, 24.5, 23.3 6, 170.8, 148.5, 148.3, 144.3, 128.6, 127.2, 126.7, 113.6, 113.2, 84.2, 74.7, 58.7, 49.9, 47.2, 45.9, 45.7, 44.0, 36.3, 36.1, 32.4, 29.7, 23.9, 21. 8, 153.3, 148.7, 144.6, 128.6, 127.2, 126.7, 113.7, 110.9, 84.3, 73.5, 58.7, 49.6, 47.3, 46.3, 45.8, 43.6, 38.8, 35.9, 32.4, 29.7, 24. 8, 170.9, 148.8, 148.5, 143.2, 140.5, 134.0, 130.8, 129.1, 127.4, 126.1, 125.7, 125.5, 123.0, 121.5, 113.4, 113.0, 84.3, 74.8, 53.9, 49.9, 48.0, 46.6, 45.5, 45.0, 43.9, 36.4, 32.5, 24.8, 23.3, 21.4 9, 153.4, 148.9, 140.4, 134.1, 131.5, 129.0, 127.4, 125.8, 125.7, 125.4, 123.4, 123.0, 113.5, 110.8, 84.3, 73.6, 53.9, 49.6, 47.9, 46.0, 45.2, 43.5, 38.8, 36.1, 32.5, 23.3 177.7, 170.8, 148.6, 148.4, 143.1, 140.3, 133.9, 130.7, 129.0, 127.2, 126.0, 125.6, 125.4, 122.9, 121.4, 113.3, 112.9, 84.1, 74.7, 53.8, 49.8, 47.9, 46.4, 45.4, 44.9, 43.8, 36.3, 32.3, 24.7, 23 125. 7, 125.6, 125.3, 123.2, 122.9, 113.4, 110.6, 84.2, 76.7, 73.5, 53.8, 49.5, 47.8, 45.9, 45.0, 43.4, 38.7, 36.0, 32.3, 23 7, 153.3, 149.4, 112.0, 108.2, 84.2, 72.4, 66.9, 56.9, 51.8, 50.8, 48.9, 44.8, 42.9, 38.0, 35.5, 33.6, 33.5, 32 4, 170.9, 148.8, 148.4, 113.5, 113.4, 83.9, 74.8, 57.6, 57.6, 53.5, 53.5, 50.1, 47.9, 47.9, 45.2, 44.2, 36.4, 36.3, 32.8, 21.4 3R, 3aS, 6aR, 8S, 9aR, 3aS, 6aR, 8S, 9aR, furan-3-yl)methyl)piperazin-1-yl)methyl)-6,9-dimethyl-ene-2-oxododeca hydroazuleno [4,5-b] 4, 177.3, 170.8, 153.4, 148.9, 148.8, 148.4, 113.5, 113.5, 113.3, 111.0, 83.9, 83.8, 74.8, 73.6, 58.6, 57.6, 57.5, 53.5, 50.1, 49.8, 48.2, 47.8, 45.2, 44.1, 43.8, 38.9, 36.4, 36.2, 36.0, 32.8, 21.3, 8. 8, 148.6, 148.3, 113.5, 113.4, 83.7, 74.7, 66.9, 58.0, 54.0, 50.1, 47.8, 44.9, 44.1, 36.3, 36.1, 32.7, 21.3 177.3, 153.3, 148.8, 113.5, 111.1, 83.8, 73.6, 66.9, 58.0, 54.1, 49.7, 48.2, 45.0, 43.7, 38.8, 35.9, 32.8 21 (m, 3H), 2.09-1.99 (m, 2H), 1.99-1.92 (m, 1H),  1.91-1.84 (m, 1H), 1.82-1.77 (m, 2H), 1.76-1.70 (m, 1H) 3, 153.3, 148.9, 113.4, 110.8, 83.9, 73.5, 54.5, 54.4, 49.6, 47.7, 46.3, 43.5, 38.8, 36.2, 32.6, 23.5 6, 153.4, 149.0, 113.5, 110.9, 84.0, 73.6, 57.7, 54.6, 49.7, 48.3, 44.7, 43.6, 38.8, 36.1, 32.5, 29.8, 25.3, 23.8 4, 176.1, 153.4, 148.8, 113.7, 111.1, 84.1, 73.6, 60.7, 51.8, 49.7, 48.0, 46.1, 46.0, 43.7, 42.6, 38.9, 35.9, 32.5, 25.0, 22.8, 22.3 153.4, 148.9, 113.7, 110.9, 84.1, 73.6, 68.9, 59.4, 49.5, 48.1, 45.1, 43.6, 38.9, 36.2, 32.6 (3aS,6aR,8S,9aR,9bS)-3-((E)-4-Methylbenzylidene)-6,9-dimethylene-2-oxododecahydroazuleno [4,5-b] 8, 170.9, 148.0, 147.5, 139.9, 138.1, 131.0, 129.7, 129.3, 128.4, 114.7, 113.8, 83.7, 74.7, 50.6, 45.2, 43.5, 36.7, 33.3, 28.4, 21.5 170.9, 170.8, 147.9, 146.9, 135.9, 134.7, 132.8, 131.7, 129.2, 128.6, 125.9, 125.9, 122.4, 115.1, 114.2, 83.6, 74.6, 50.6, 45.3, 43.3, 36.7, 32.3, 28.1, 21.3 3, 170.8, 147.9, 147.2, 136.5, 135.4, 132.4, 130.8, 130.3, 128.9, 115.0, 114.1, 83.5, 74.6, 50.6, 45.2, 43.4, 36.7, 32.9, 28.3, 21.3 .9, 170.9, 148.6, 148.0, 147.8, 132.4, 129.3, 122.7, 119.7, 116.4, 115.4, 114.3, 113.7, 83.1, 74.7, 56.5, 50.3, 46.4, 44.7, 36.5, 34.3, 30.6, 21.3 8, 170.8, 149.1, 147.9, 146.9, 134.7, 133.9, 133.2, 132.6, 131.9, 126.6, 125.1, 115.3, 114.1, 83.6, 74.6, 50.6, 45.2, 43.3, 36.6, 32.5, 28.2, 21.2, 20.5 1, 170.8, 168.5, 147.9, 147.0, 136.0, 135.4, 133.9, 130.7, 127.4, 123.8, 115.2, 114.1, 83.6, 74.6, 50.6, 45.3, 43.2, 36.7, 32.4, 28.1, 24.9, 21.3; HRMS (ESI) 4, 170.9, 148.0, 147.4, 137.5, 136.9, 133.4, 130.6, 130.3, 129.3, 127.9, 125.7, 114.6, 114.1, 83.4, 74.7, 50.7, 45.1, 43.9, 36.6, 33.0, 28.7, 21.3, 19.9; HRMS (ESI) 6aR, 8S, 9aR, 0, 170.8, 166.6, 147.9, 147.3, 138.3, 136.4, 132.2, 130.9, 129.3, 128.9, 128.8, 128.4, 114.5, 114.3, 83.0, 74.7, 52.4, 50.8, 45.2, 43.7, 36.6, 32.6, 29.0, 21.3 6, 170.9, 148.0, 147.4, 138.0, 133.9, 129.6, 129.4, 128.6, 128.4, 114.8, 113.9, 83.6, 74.7, 50.6, 45.2, 43.5, 36.7, 33.1, 28.4, 21.3 170.3, 147.7, 147.5, 146.9, 134.2, 133.6, 132.5, 130.8, 130.1, 129.9, 125.1, 114.9, 114.6, 82.9, 74.6, 50.7, 45.2, 43.7, 36.6, 32 8, 170.0, 147.9, 147.6, 146.7, 135.8, 133.7, 133.3, 132.8, 131.2, 129.1, 125.4, 115.1, 114.7, 82.8, 74.6, 50.8, 45.2, 43.7, 36.6, 32.0, 29.1, 21.3 9, 170.4, 147.8, 147.4, 147.0, 140.8, 134.3, 132.0, 129.9, 127.8, 125.4, 124.9, 114.8, 114.5, 82.9, 74.6, 50.7, 45.2, 43.8, 36.6, 32.3, 29.0, 21.3 
Biology
Anticancer studies. Compounds were dissolved in DMSO (Sigma) to prepare 50 mM concentrations stock solutions. All the further dilutions were also made in DMSO. During the treatment, the nal concentration of DMSO was maintained <0.02%.
Antibodies. Anti-caspase 9 and anti-caspase 3 antibodies were purchased from Cell Signaling and anti-a-tubulin antibody was procured from Sigma, aoat anti-rabbit HRP conjugated secondary antibody was purchased from Bio-Rad, and goat antimouse HRP conjugated secondary antibody was purchased from Cell Signaling.
Cell culture. Breast cancer cell line MCF7 was grown in DMEM (GIBCO), MBA-MB-231 in RPMI (GIBCO) with 10% FBS, 100 U mL À1 penicillin and 100 mg mL À1 streptomycin and MCF10A in DMEM/F12 (Gibco) containing, horse Serum (10% nal), EGF (20ng ml À1 ), hydrocortisone (0.5 mg mL À1 ), cholera toxin (100 ng mL À1 ), insulin (10 mg mL À1 ) and penicillin/ streptomycin mix (1mL/100ml) at 37 C in a humid, 5% CO 2 regulated incubator. Growth inhibition by cytotoxicity assay. The cytotoxic effect of the compounds was determined using MTT (3-(4,5 dimethylthiazol-2-yl)-2-5 diphenyltetrazolium bromide) assay. Cells were seeded (4 Â 10 3 per well) in 96 well plates. Aer 24 hours of seeding, cells were exposed with varying concentrations (0-100 mM) of respective compounds for 48 hours in triplicates. Then, MTT solution (20 mL of 5 mg mL À1 stock for each well of 96 well plate) was added and further incubated for 3.5 hours in humid 5% CO 2 incubator. Media containing MTT solution was then replaced by MTT solvent (iso-propanol, HCl and Triton X-100), incubated for 15 min at room temperature with gentle shaking for complete dissolution of Formazan. Absorbance was measured at 570 nm using a Thermo Scientic Multiskan G0 Elisa plate reader. All experiments were carried out at least in triplicate, and the percentage of viable cells was calculated as the mean with respect to the controls. Western blot analysis. The cells were harvested, washed with 1Â PBS and were lysed in lysis buffer (50 mM Tris pH 7.4, 5 mM EDTA, 250 mM NaCl, 10 mM sodium uoride, 0.5 mM sodium orthovanadate and 0.5% Triton X100) with 100 mL lysis buffer per 35 mm cell culture plate. The lysate was incubated on ice for 20 minutes followed by centrifugation at 16000 Â g for 20 minutes at 4 C. The supernatant was collected, and the protein content was estimated by Bradford method using bovine serum albumin as a standard. The protein samples were prepared in 1Â Laemmlli buffer and boiled for 5 minutes. The protein samples were then resolved by SDS-PAGE and transferred onto polyvinylidene uoride membrane (Merck Millipore, Billerica, MA, USA). Skimmed milk (3%) in 0.05% Tween (TBST) was used for blocking the membrane for 1 h. The membrane was then washed and incubated with the respective primary antibodies at 4 C for overnight. The membrane was then washed thrice with TBST and incubated with respective HRP conjugated secondary antibody. Protein bands were detected using the Super Signal West Pico substrate (Thermo Scientic).
Cell cycle analysis by uorescence-activated cell shortening (FACS). Cells were seeded one-day prior the treatment of compounds. Next day cells were incubated with and without selected compounds for 24 h and were then collected for FACS analysis. Propidium iodide staining was performed for the total DNA content of the cells. Briey, the cells were washed with 1Â PBS, trypsinized and then spin down at 3000 Â g for 2 minutes at 4 C. The cell pellet obtained was xed and permeabilized using 900 mL of 95% chilled ethanol, which was added dropwise along with continuous vortexing. The cells were then stored overnight at 4 C. The xed cells were then pelleted at 3000 Â g for 2-3 minutes. The supernatant was discarded, and the pellet was washed twice with 1Â PBS. The pellet was dissolved and stained with 1 mL staining solution (900 mL 1Â PBS, 2 mM MgCl 2 ), 50 mL propidium iodide stock solution (5 mg mL À1 of 1Â PBS) 50 mL RNase stock solution (1 mg mL À1 ) and incubated at 37 C for 20 minutes. Cells were then passed through cell strainers and proceed for FACS accusation on BD FACS Calibur. The data were then analyzed using Cell Quest pro soware. DNA fragmentation assay. DNA fragmentation assay was done aer treating MCF7 cells with respective compounds as per the protocol described previously. 15 The fragmentation ladder of the DNA was observed on a 2% agarose gel.
Immunostaining. The cells were grown on a cover slip as a monolayer overnight. The cells were then exposed with respective compounds at IC 50 concentration and incubated for 12 hours. The cells on coverslips were xed in 3.7% formaldehyde for 20 minutes in the dark at room temperature. The cover slips were washed 2-3 times with 1Â PBS. The cells were then permeabilized by 0.5% Tween-20 at room temperature for 30 minutes and then washed with PBS for 4 times. The permeabilized cells were blocked with 3% BSA followed by staining with a-tubulin (Sigma) in 3% BSA solution for 1 h at room temperature. The cells were washed with 1Â PBS 5 times and then stained with ALEXA Flour 594 conjugated secondary antibody for 1 h and then washed with 1Â PBS for 5 times. Finally, DNA was stained with Hoechst and coverslips were mounted on slides in mounting media (8 mg mL À1 DABCO in 80% glycerol and 20% PBS).
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